The Middle East and Africa (MEA) Aesthetic Injectable Devices Market is projected to grow significantly, with an expected market size of approximately US$ 630.2 million by 2031, up from US$ 393.3 million in 2024. This growth represents a compound annual growth rate (CAGR) of 7.1% from 2025 to 2031.
Moreover, improvements in healthcare infrastructure and technology, along with a rise in medical tourism, are enhancing accessibility to these aesthetic procedures. The growing number of qualified dermatologists and cosmetic surgeons in the region is also facilitating this trend, making aesthetic treatments more available to a broader audience.
According to the International Society of Aesthetic Plastic Surgery (ISAPS), there were 19.1 million non-surgical procedures performed globally in 2023. The most popular among these were hyaluronic acid and botulinum toxin treatments, with botulinum toxin being the most performed non-surgical procedure across all demographics, totaling 8.8 million treatments in 2023. Hyaluronic acid procedures also saw a significant increase, with a total of 5.5 million procedures performed, marking a 29% rise.
The increasing popularity of non-surgical enhancements and the growing patient base are driving the demand for aesthetic injectable devices, thereby propelling market growth.
The aging population, increasing disposable incomes, and evolving lifestyle trends in both southern and northern Africa are expected to further bolster the growth of the aesthetic injectable devices market. The demand for non-invasive procedures that mitigate signs of aging is on the rise, particularly as the population ages. As reported by the National Osteoporosis Foundation of South Africa, approximately 16% of the South African population was over 50 years old in 2022, a figure projected to increase significantly over the next two decades. This demographic shift is expected to drive demand for anti-aging treatments, highlighting a strong consumer interest in wrinkle reduction and facial rejuvenation therapies.
Executive Summary and Market Analysis
The MEA region, which includes countries such as the UAE, Saudi Arabia, and South Africa, is experiencing a notable expansion in the aesthetic injectable devices market. This surge in demand is primarily driven by increasing awareness and acceptance of cosmetic procedures across various demographics, including younger consumers and affluent individuals. Non-invasive treatments, particularly Botox and dermal fillers, are favored for their minimal recovery times and immediate visible results, contributing significantly to market growth.Moreover, improvements in healthcare infrastructure and technology, along with a rise in medical tourism, are enhancing accessibility to these aesthetic procedures. The growing number of qualified dermatologists and cosmetic surgeons in the region is also facilitating this trend, making aesthetic treatments more available to a broader audience.
Strategic Insights
Market Segmentation Analysis
The MEA Aesthetic Injectable Devices Market can be segmented based on several criteria:
- By Product: The market is divided into Dermal Fillers, Botulinum Toxin, and Others. In 2024, Botulinum Toxin held the largest market share.
- By Dermal Fillers: This segment includes Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate (PMMA), Fat Fillers, and Others. Hyaluronic Acid was the leading product in this category in 2024.
- By Device: The market is categorized into Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others, with Pre-Filled Syringes dominating the market share in 2024.
- By Application: Applications include Facial Line Correction, Face Lift, Lip Treatment, Anti-Aging and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others. Facial Line Correction was the most significant application in 2024.
- By Age Group: The market is segmented into Up to 30, 31-40, 41-50, 51-60, and More Than 60, with the 31-40 age group holding the largest share in 2024.
- By Gender: The market is divided into Female and Male, with females representing the majority of the market share in 2024.
- By End User: This includes Medical Spas, Dermatology Clinics, Hospitals, and Others, with Dermatology Clinics leading the market in 2024.
Market Outlook
The preference for aesthetic injectables over traditional surgical procedures is growing due to their lower risks, quicker recovery times, and effective results without the need for invasive surgery. Treatments such as Botox and hyaluronic acid fillers are effective in addressing skin concerns like wrinkles, fine lines, and loss of facial volume. The global trend towards non-surgical aesthetic procedures is on the rise, as many individuals prioritize their appearance as a key aspect of their overall well-being.According to the International Society of Aesthetic Plastic Surgery (ISAPS), there were 19.1 million non-surgical procedures performed globally in 2023. The most popular among these were hyaluronic acid and botulinum toxin treatments, with botulinum toxin being the most performed non-surgical procedure across all demographics, totaling 8.8 million treatments in 2023. Hyaluronic acid procedures also saw a significant increase, with a total of 5.5 million procedures performed, marking a 29% rise.
The increasing popularity of non-surgical enhancements and the growing patient base are driving the demand for aesthetic injectable devices, thereby propelling market growth.
Country Insights
The MEA Aesthetic Injectable Devices Market is further segmented by country, including Saudi Arabia, South Africa, the UAE, and the Rest of the MEA. South Africa held the largest market share in 2024. According to ISAPS, South Africa performed a total of 85,869 aesthetic procedures in 2023, with 48,486 being non-surgical, predominantly involving injectable treatments like botulinum toxin and hyaluronic acid.The aging population, increasing disposable incomes, and evolving lifestyle trends in both southern and northern Africa are expected to further bolster the growth of the aesthetic injectable devices market. The demand for non-invasive procedures that mitigate signs of aging is on the rise, particularly as the population ages. As reported by the National Osteoporosis Foundation of South Africa, approximately 16% of the South African population was over 50 years old in 2022, a figure projected to increase significantly over the next two decades. This demographic shift is expected to drive demand for anti-aging treatments, highlighting a strong consumer interest in wrinkle reduction and facial rejuvenation therapies.
Company Profiles
Key players in the MEA Aesthetic Injectable Devices Market include Merz Pharma GmbH & Co KGaA, AbbVie Inc, Ipsen SA, Mesoestetic E-Commerce SL, Galderma SA, Revance Therapeutics Inc, Medytox Inc, Sinopharm Group Co Ltd, Evolus Inc, Hugel Inc, Sinclair Pharma Ltd, and Laboratoires Vivacy, S.A.S. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Aesthetic Injectable Devices Market Landscape
4. Middle East & Africa Aesthetic Injectable Devices Market - Key Market Dynamics
5. Aesthetic Injectable Devices Market - Middle East & Africa Market Analysis
6. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Product
7. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Dermal Fillers
8. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Device
9. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Application
10. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Age Group
11. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by Gender
12. Middle East & Africa Aesthetic Injectable Devices Market Revenue Analysis - by End User
13. Middle East & Africa Aesthetic Injectable Devices Market - Country Analysis
14 Competitive Landscape
15 Industry Landscape
17 COMPANY PROFILES
17. Appendix
LIST OF TABLES
LIST OF FIGURES
Companies
The List of Companies - Middle East & Africa Aesthetic Injectable Devices MarketMerz Pharma GmbH & Co KGaA
AbbVie Inc
Ipsen SA
Mesoestetic E-Commerce SL
Galderma SA
Revance Therapeutics Inc
Medytox Inc
Sinopharm Group Co Ltd
Evolus Inc
Hugel Inc
Sinclair Pharma Ltd
Laboratoires Vivacy, S.A.S.
